Natural Alternatives International, Inc. engages in formulating, manufacturing, and marketing nutritional supplements in the United States and internationally. It operates through two segments, Private-Label Contract Manufacturing, and Patent and Trademark Licensing. The company offers private-label contract manufacturing services to companies that market and distribute vitamins, minerals, herbal, and other nutritional supplements, as well as other health care products. It also provides strategic partnering services, such as customized product formulation, clinical studies, manufacturing, marketing support, international regulatory and label law compliance, international product registration, packaging in multiple formats and labeling design, scientific research, proprietary ingredients, customer-specific nutritional product formulation, product testing and evaluation, packaging and delivery system design, and regulatory review. In addition, the company sells beta-alanine ingredient under the CarnoSyn and SR CarnoSyn names. It manufactures products in various forms, including capsules, tablets, chewable wafers, and powders. The company's private-label contract manufacturing customers include companies that market nutritional supplements through direct sales marketing channels, direct to consumer e-commerce channels, and retail stores. Natural Alternatives International, Inc. was founded in 1980 and is headquartered in Carlsbad, California.
Industry, Sector and Symbol
Industry Medicinals & botanicals
Sub-IndustryN/A
SectorMedical
Phone760-744-7700
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$132.44 million
Profitability
Miscellaneous
Employees174
OptionableNot Optionable
Natural Alternatives International (NASDAQ:NAII) Frequently Asked Questions
What is Natural Alternatives International's stock symbol?
Natural Alternatives International trades on the NASDAQ under the ticker symbol "NAII."
How will Natural Alternatives International's stock buyback program work?
Natural Alternatives International declared that its Board of Directors has authorized a share repurchase program on Tuesday, April 11th 2017, which permits the company to buyback $2,000,000.00 in outstanding shares, according to EventVestor. This buyback authorization permits the company to purchase up to 3.5% of its shares through open market purchases. Shares buyback programs are typically a sign that the company's leadership believes its shares are undervalued.
How were Natural Alternatives International's earnings last quarter?
Natural Alternatives International, Inc. (NASDAQ:NAII) released its quarterly earnings data on Tuesday, November, 13th. The company reported $0.37 EPS for the quarter. The company earned $36.53 million during the quarter. Natural Alternatives International had a return on equity of 14.07% and a net margin of 4.38%. View Natural Alternatives International's Earnings History.
When is Natural Alternatives International's next earnings date?
Has Natural Alternatives International been receiving favorable news coverage?
Media headlines about NAII stock have trended positive this week, according to InfoTrie Sentiment. The research firm rates the sentiment of media coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Natural Alternatives International earned a media sentiment score of 2.7 on InfoTrie's scale. They also assigned press coverage about the company a news buzz of 1.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the stock's share price in the near term.
Who are some of Natural Alternatives International's key competitors?
Some companies that are related to Natural Alternatives International include Foamix Pharmaceuticals (FOMX), Chromadex (CDXC), Mediwound (MDWD), China Jo-Jo Drugstores (CJJD), Mannatech (MTEX), Pharmacyte Biotech (PMCB), GLG Life Tech (GLGLF), Cyanotech (CYAN), FitLife Brands (FTLF), Tauriga Sciences (TAUG), True Drinks (TRUU), Nutra Pharma (NPHC), Entia Biosciences (ERGO), Rock Creek Pharmaceuticals (RCPIQ) and Beleave (BE).
Who are Natural Alternatives International's key executives?
Natural Alternatives International's management team includes the folowing people:
- Mr. Mark A. LeDoux, Chairman & CEO (Age 65)
- Mr. Kenneth E. Wolf, Pres, COO, Sec. & Treasurer (Age 58)
- Mr. Michael E. Fortin, Chief Financial Officer (Age 42)
- Mr. Eugene M. Quast, VP of Global Sales (Age 60)
- Dr. Fausto Petrini Ph.D., Director of Operations
How do I buy shares of Natural Alternatives International?
Shares of NAII can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Natural Alternatives International's stock price today?
One share of NAII stock can currently be purchased for approximately $10.96.
How big of a company is Natural Alternatives International?
Natural Alternatives International has a market capitalization of $82.98 million and generates $132.44 million in revenue each year. Natural Alternatives International employs 174 workers across the globe.
What is Natural Alternatives International's official website?
How can I contact Natural Alternatives International?
Natural Alternatives International's mailing address is 1535 Faraday Ave, Carlsbad CA, 92008. The company can be reached via phone at 760-744-7700 or via email at [email protected]
MarketBeat Community Rating for Natural Alternatives International (NASDAQ NAII)
MarketBeat's community ratings are surveys of what our community members think about Natural Alternatives International and other stocks. Vote "Outperform" if you believe NAII will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NAII will underperform the S&P 500 over the long term. You may vote once every thirty days.
